Long-term Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis

Condition(s) studied

Investigational drug(s) / intervention(s)

Sacral nerve stimulation: Device: G132 system, Beijing PINS Medical Co., China Neuromodulation was performed according to the usual protocol

Study summary

Although the incidence of inflammatory bowel disease is stable in North American and European countries, the incidence of inflammatory bowel disease is increasing in newly industrialized countries, especially in China. The treatment drugs for ulcerative colitis include 5-aminosalicylic acid (5-ASA), glucocorticoids, immunosuppressants, and biological agents. The aim of this clinical trial is to evaluate the long-term safety and efficacy of sacral nerve stimulation in patients with ulcerative colitis

Eligibility

Primary outcome measure(s)

• Change from baseline in the Mayo score — From baseline to 8 years
  The range of Mayo score is 0-12, and higher scores mean worse outcome

Trial sites (1)

More Xijing Hospital trials in China

Other trials for the same condition